Search the Newsreel

Adlai Nortye Ltd (ANL) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Adlai Nortye Ltd (ANL), detailing its support, resistance levels, and various technical indicators. It presents current indicator values and directions (Buy, Sell, Neutral) for tools like MACD, RSI, and moving averages. The analysis concludes with a Neutral …

Vera Bradley, Inc. Revenue Breakdown – NASDAQ:VRA

Vera Bradley, Inc. (NASDAQ:VRA) generated $269.65 million in revenue last year, with its Vera Bradley Direct segment being the top performer, contributing $227.79 million. The vast majority of its revenue, $269.65 million, came from the United States. This represents a decrease from the previous …

VRA|Vera Bradley Inc|Price:3.690|Chg%:+0.010

Vera Bradley Inc. (VRA) is trading at $3.69, up 0.27%, with positive year-to-date and 1-year performance. The company's fundamentals are robust, but its stock is currently in a sideways trading pattern, rated as "Hold" by analysts with a target price of $5.50. Institutional ownership …

Vera Bradley Inc (VRA) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis of Vera Bradley Inc (VRA), noting its current valuation score of 7.85 and ranking within the Textiles & Apparel industry. It highlights the company's P/E ratio of -2.15, comparing it to recent highs and lows. The analysis also …

Headlam Group plc Revenue Breakdown – LSE:HEAD

Vera Bradley Enhances Executive Severance and Retention Protections

Vera Bradley (VRA) has implemented new Executive Severance Plan Agreements for its COO/CFO Martin Layding and CBO Melinda Paraie. These agreements provide severance benefits and retention incentives, including salary, bonuses, COBRA payments, and accelerated stock vesting, contingent on non-compete and confidentiality clauses. This move …

Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor Fitzgerald

Cantor Fitzgerald analyst Li Watsek has reiterated a Buy rating for Adlai Nortye Ltd. Sponsored ADR (ANL) with the company having an analyst consensus of Strong Buy and a price target of $25.50, representing a 124.67% upside. H.C. Wainwright also maintained a Buy rating …

Adlai Nortye (Nasdaq: ANL) revises selling shareholders for 98.6M registered shares

Adlai Nortye Ltd. has updated its resale registration for approximately 98.6 million Class A ordinary shares (represented by nearly 32.9 million ADSs) by reattributing certain shares among selling shareholders. The change specifies that SILV Fund, Ltd. is now listed as the selling shareholder for …

Vera Bradley (VRA) Q2 2026 Earnings: EPS Surprise of 73% on Better-Than-Expected Bottom Line, but Stock Slides

Adlai Nortye (NASDAQ: ANL) doses first patient in weekly AN9025 trial arm

Adlai Nortye Ltd. announced the dosing of the first U.S. patient in the intermittent weekly (QW) arm of its global Phase 1 trial for AN9025, an oral pan-RAS(ON) inhibitor for advanced solid tumors with RAS mutations. Both the once-daily (QD) and weekly (QW) dose-escalation …

Adlai Nortye doses first patient in weekly trial arm of AN9025

Adlai Nortye Ltd. has dosed the first patient in the weekly dosing arm of its Phase 1 clinical trial for AN9025, a pan-RAS(ON) inhibitor, in the United States. While the company's shares trade at $10.63 with a market capitalization of $425 million, InvestingPro suggests …

Adlai Nortye Starts Weekly Dosing Test for RAS-Mutated Solid Tumors

Adlai Nortye (NASDAQ: ANL) announced that the first patient has been dosed in the intermittent weekly (QW) arm of its global Phase 1 trial for AN9025, a pan-RAS(ON) inhibitor. This trial is for advanced or metastatic solid tumors with RAS mutations, with both once-daily …

Vera Bradley Is Slowly Turning The Ship Around, But It's Not Enough (Rating Downgrade)

SRAIL Prognose — Kursziel für 2027

Ian Bickley Bought 2.4% More Shares In Vera Bradley

Vera Bradley posts first quarterly revenue growth since fiscal 2022

Vera Bradley earnings missed by $0.26, revenue fell short of estimates

VERA BRADLEY ($VRA) Releases Q1 2027 Earnings

Vera Bradley Announces First Quarter Fiscal Year 2027 Results

Vera Bradley Q1 Earnings Call Highlights

Vera Bradley (VRA) Reports Q1 Loss, Tops Revenue Estimates

Vera Bradley Stock Jumps After Q1 Double Beat — First Revenue Growth in Four Years - Vera Bradley (NASDAQ

Vera Bradley schedules June 11 call on first‑quarter FY 2027 results

Vera Bradley, Inc. Announces Reporting Date for First Quarter Fiscal Year 2027 Results

Here's Why Adlai Nortye Ltd. Sponsored ADR (ANL) Is a Great 'Buy the Bottom' Stock Now

Vera Bradley Board Ends Shareholder Rights Plan Early

Vera Bradley board scraps takeover defense six months early

Cancer drug developer Adlai Nortye lines up $150M from investors

Vera Bradley: A Colorful Turnaround (NASDAQ:VRA)

Adlai Nortye (ANL) Loss Narrows To US$18.3 Million Challenging Bearish Cash Burn Narrative

Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why

Vera Bradley Inc (VRA) Q4 2026 Earnings Call Highlights: A Return to Profitability Amidst ...

Vera Bradley, Inc. Announces Reporting Date For Fourth Quarter and Fiscal Year 2026 Results

Adlai Nortye Announces $140.0 Million Private Placement Equity Financing

Individual investors are Adlai Nortye Ltd.'s (NASDAQ:ANL) biggest owners and were rewarded after market cap rose by US$65m last week

Adlai Nortye Ltd.'s (NASDAQ:ANL) market cap surged US$65m last week, retail investors who have a lot riding on the company were rewarded